Kronos Bio, Inc. 8-K/A SEC Filings

On April 7, 2023, we appointed Katherine Vega Stultz to our Board of Directors (the “Board”) as a Class II director with a term ending at our annual meeting of stockholders to be held in 2025. Ms. Stultz’s appointment to the Board became...

On April 20, 2023, we appointed Roger Dansey, M.D. to our Board of Directors (the “Board”) as a Class I director with a term ending at our annual meeting of stockholders to be held in 2024. On May 26, 2023, Dr. Dansey was appointed as a ...

On January 21, 2023, Marianne De Backer, Ph.D., notified us of her decision to resign from our board of directors as a result of her recent appointment as Chief Executive Officer of Vir Biotechnology, Inc., and in consideration of her ad...